Vaccine Materials Scientist – Postdoctoral Fellow

The University of Texas at Austin; Austin (TX); On-site; USD 50,835 - 62,132; Full time

Benefits offered by this job

Comprehensive benefits package

Professional development opportunities

Paid vacation and sick leave

Job summary

A leading educational institution in Austin is looking for a Postdoctoral Fellow to facilitate cutting-edge research on cell viability and vaccine performance. The ideal candidate will hold a Ph.D. in a related field and have strong skills in experimental design and research publication. The position offers a competitive salary, comprehensive benefits, and the opportunity for professional development. Responsibilities include performing experiments, data analysis, and publishing findings. The role is expected to start immediately and run until December 31, 2024.

Qualifications

• Ph.D. degree in relevant field earned within three years of start date.
• Demonstrated ability to publish novel research in peer-reviewed journals.
• Experience in aseptic technique and animal work preferred.

Responsibilities

• Perform general experiments including protocol design for vaccine formulations.
• Conduct in vivo experiments and data analysis.
• Publish and present research findings.

Skills

Adaptability to interdisciplinary research

Time management

Critical thinking

Interpersonal communication

Research publication

Education

Ph.D. in Materials Science, Bioengineering, or related life sciences

Tools

Flow cytometry

Virus-based assays

Bioinformatics

Job description

A leading educational institution in Austin is looking for a Postdoctoral Fellow to facilitate cutting-edge research on cell viability and vaccine performance. The ideal candidate will hold a Ph.D. in a related field and have strong skills in experimental design and research publication. The position offers a competitive salary, comprehensive benefits, and the opportunity for professional development. Responsibilities include performing experiments, data analysis, and publishing findings. The role is expected to start immediately and run until December 31, 2024.